Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cancer hypoxia:

Hypoxia: A Double-Edged Sword in Cancer Therapy. Manoochehri Khoshinani H et al. Cancer Invest. (2016)

Intermittent hypoxia and cancer: Undesirable bed partners? Almendros I et al. Respir Physiol Neurobiol. (2018)

The role of hypoxia in oral cancer and potentially malignant disorders: a review. Kujan O et al. J Oral Pathol Med. (2017)

Search results

Items: 1 to 20 of 26538

1.

Bifunctional liposomes reduce the chemotherapy resistance of doxorubicin induced by reactive oxygen species.

Xu L, Zhang Z, Ding Y, Wang L, Cheng Y, Meng L, Wu J, Yuan A, Hu Y, Zhu Y.

Biomater Sci. 2019 Sep 16. doi: 10.1039/c9bm00590k. [Epub ahead of print]

PMID:
31524211
2.

New power of self-assembling carbonic anhydrase inhibitor: Short peptide-constructed nanofibers inspire hypoxic cancer therapy.

Li J, Shi K, Sabet ZF, Fu W, Zhou H, Xu S, Liu T, You M, Cao M, Xu M, Cui X, Hu B, Liu Y, Chen C.

Sci Adv. 2019 Sep 6;5(9):eaax0937. doi: 10.1126/sciadv.aax0937. eCollection 2019 Sep.

PMID:
31523712
3.

A novel tumor spheroid model identifies selective enhancement of radiation by an inhibitor of oxidative phosphorylation.

Karlsson H, Senkowski W, Fryknäs M, Mansoori S, Linder S, Gullbo J, Larsson R, Nygren P.

Oncotarget. 2019 Sep 3;10(51):5372-5382. doi: 10.18632/oncotarget.27166. eCollection 2019 Sep 3.

PMID:
31523395
4.

Aberrations in Notch-Hedgehog signalling reveal cancer stem cells harbouring conserved oncogenic properties associated with hypoxia and immunoevasion.

Chang WH, Lai AG.

Br J Cancer. 2019 Sep 16. doi: 10.1038/s41416-019-0572-9. [Epub ahead of print]

PMID:
31523055
5.

Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial.

Luu T, Frankel P, Beumer JH, Lim D, Cristea M, Appleman LJ, Lenz HJ, Gandara DR, Kiesel BF, Piekarz RL, Newman EM.

Cancer Chemother Pharmacol. 2019 Sep 14. doi: 10.1007/s00280-019-03955-7. [Epub ahead of print]

PMID:
31522242
6.

Hypoxia induced cancer stem cell enrichment promotes resistance to androgen deprivation therapy in prostate cancer.

O'Reilly D, Johnson P, Buchanan PJ.

Steroids. 2019 Sep 12:108497. doi: 10.1016/j.steroids.2019.108497. [Epub ahead of print] Review.

PMID:
31521707
7.

Proteomics evaluation of MDA-MB-231 breast cancer cells in response to RNAi-induced silencing of hPTTG.

Khazaei G, Shamsabadi FT, Yamchi A, Golalipour M, Jhingan GD, Shahbazi M.

Life Sci. 2019 Sep 12:116873. doi: 10.1016/j.lfs.2019.116873. [Epub ahead of print]

PMID:
31521689
8.

The dark proteome of cancer: Intrinsic disorderedness and functionality of HIF-1α along with its interacting proteins.

Garg N, Kumar P, Gadhave K, Giri R.

Prog Mol Biol Transl Sci. 2019;166:371-403. doi: 10.1016/bs.pmbts.2019.05.006. Epub 2019 Jun 8.

PMID:
31521236
9.

The role of collagen in cancer: from bench to bedside.

Xu S, Xu H, Wang W, Li S, Li H, Li T, Zhang W, Yu X, Liu L.

J Transl Med. 2019 Sep 14;17(1):309. doi: 10.1186/s12967-019-2058-1. Review.

10.

Monitoring Oxygenation Levels Deep in the Tumor Core: Noninvasive Imaging of Hypoxia, Now in Real-Time 3D.

Klibanov AL, Hu S.

Cancer Res. 2019 Sep 15;79(18):4577-4579. doi: 10.1158/0008-5472.CAN-19-2151.

PMID:
31519775
11.

Hypoxia-induced PGC-1α Regulates Mitochondrial Function and Tumorigenesis of Colorectal Cancer Cells.

Yun CW, Lee JH, Lee SH.

Anticancer Res. 2019 Sep;39(9):4865-4876. doi: 10.21873/anticanres.13672.

PMID:
31519589
12.

Controlling the Phenotype of Tumor-Infiltrating Macrophages via the PHD-HIF Axis Inhibits Tumor Growth in a Mouse Model.

Nishide S, Matsunaga S, Shiota M, Yamaguchi T, Kitajima S, Maekawa Y, Takeda N, Tomura M, Uchida J, Miura K, Nakatani T, Tomita S.

iScience. 2019 Aug 28;19:940-954. doi: 10.1016/j.isci.2019.08.033. [Epub ahead of print]

13.

Hypoxic drive caused Type 3 neovascularization in a preclinical model of exudative age-related macular degeneration.

Zhang L, Cui X, Han Y, Park KS, Gao X, Zhang X, Yuan Z, Hu Y, Hsu CW, Li X, Bassuk AG, Mahajan VB, Wang NK, Tsang SH.

Hum Mol Genet. 2019 Sep 13. pii: ddz159. doi: 10.1093/hmg/ddz159. [Epub ahead of print]

PMID:
31518400
14.

Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer.

Chen K, Ye J, Qi L, Liao Y, Li R, Song S, Zhou C, Feng R, Zhai W.

Anticancer Drugs. 2019 Oct;30(9):925-932. doi: 10.1097/CAD.0000000000000797.

PMID:
31517732
15.

Transcriptomics Identify a Unique Intermittent Hypoxia Mediated Profile in Obstructive Sleep Apnea.

Turnbull CD, Lee LY, Starkey T, Sen D, Stradling J, Petousi N.

Am J Respir Crit Care Med. 2019 Sep 13. doi: 10.1164/rccm.201904-0832LE. [Epub ahead of print] No abstract available.

PMID:
31517507
16.

Viewing Imaging Studies: How Patient Location and Imaging Site Affect Referring Physicians.

Homayounieh F, Singh R, Chen T, Sugarman EJ, Schultz TJ, Digumarthy SR, Dreyer KJ, Kalra MK.

J Digit Imaging. 2019 Sep 12. doi: 10.1007/s10278-019-00279-z. [Epub ahead of print]

PMID:
31515753
17.

Approaches to combat hypoxia in cancer therapy and the potential for in silico models in their evaluation.

Forster JC, Marcu LG, Bezak E.

Phys Med. 2019 Aug;64:145-156. doi: 10.1016/j.ejmp.2019.07.006. Epub 2019 Jul 15. Review.

PMID:
31515013
18.

Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury.

Zilberman-Itskovich S, Abu-Hamad R, Zarura R, Sova M, Hachmo Y, Stark M, Neuman S, Slavin S, Efrati S.

PLoS One. 2019 Sep 12;14(9):e0222354. doi: 10.1371/journal.pone.0222354. eCollection 2019.

19.

Nitric oxide regulates the expression of heme carrier protein-1 via hypoxia inducible factor-1α stabilization.

Kurokawa H, Ito H, Terasaki M, Matano D, Taninaka A, Shigekawa H, Matsui H.

PLoS One. 2019 Sep 12;14(9):e0222074. doi: 10.1371/journal.pone.0222074. eCollection 2019.

20.

Decreased SPTLC1 expression predicts worse outcomes in ccRCC patients.

Zhu WK, Xu WH, Wang J, Huang YQ, Abudurexiti M, Qu YY, Zhu YP, Zhang HL, Ye DW.

J Cell Biochem. 2019 Sep 12. doi: 10.1002/jcb.29390. [Epub ahead of print]

PMID:
31512789

Supplemental Content

Loading ...
Support Center